The present study was conducted to determine the effect of consuming canola oil vs. other common oil(s) on the lipid profile and anthropometric parameters of dyslipidemic adults. Eighty urban affluent dyslipidemic adults (40 experimental, 40 control) of age 30–45 years were enrolled from hospital based preventive health check programs for a 16-week non-randomized intervention trial. Dietary and lifestyle modification advice for management of lipid levels was provided to both the groups. Canola oil was provided for routine consumption only to the experimental group whilst the control group was advised to consume their usual oil(s) in recommended amounts (15ml/day). Height, weight, Body Mass Index (BMI), waist circumference (WC), Low Density Lipoprotein (LDL), High Density Lipoprotein (HDL), Total Cholesterol (TC) and Triglycerides (TG) were measured at the beginning of the study (0 weeks), post run-in period (4 weeks) and post intervention period (12 weeks). Self-reported checklist was used to measure monthly compliance. Mixed effect linear regression and quantile linear mixed models were used to analyze the change in the parameters over time. There was no significant difference in the compliance towards dietary and lifestyle advice between both the groups (p=0.525; 0.795). The difference of changes in the lipid profile and anthropometric measurements between the groups observed over time was not statistically significant (Weight: p=0.206, BMI: p=0.553, WC=0.40, TC: p=0.505, TG: p=0.167, LDL: p=0.271, HDL: p=0.504). Hence, there was no difference in the effects of consuming canola oil vs. other common oil(s) in managing dyslipidemia. Similar beneficial changes were observed with consumption of both canola as well as other common oil(s).
Baxheinrich A, Stratmann B, Lee-Barkey YH, Tschoepe D, Wahrburg U. 2012. Effects of a rapeseed oil-enriched hypoenergetic diet with a high content of α-linolenic acid on body weight and cardiovascular risk profile in patients with the metabolic syndrome. Brit J Nutr 108(4):682–691. https://doi.org/10.1017/S0007114512002875.
Bester D, Esterhuyse AJ, Truter EJ, Van Rooyen J. 2010. Cardiovascular effect of edible oils: A comparison between four popular edible oils. Nutr Res Rev 23(2):334–348. https://doi.org/10.1017/S0954422410000223.
Bumrungpert A, Chongsuwat R, Phosat C, Butacnum A. 2019. Rice bran oil containing gamma-oryzanol improves lipid profiles and antioxidant status in hyperlipidemic subjects: A randomized double-blind controlled trial. J Altern Complement Med 25(3):353–358. https://doi.org/10.1089/acm.2018.0212.
Chandra KS, Bansal M, Nair T, Iyengar SS, Gupta R, Manchanda SC, Mohanan PP, Rao VD, Manjunath CN, Sawhney JP et al. 2014. Consensus statement on management of dyslipidemia in Indian subjects. Indian Heart J 66(Suppl 3):S1–51. doi: 10.1016/j.ihj.2014.12.001.
Chauhan S, Aeri BT. 2015. The rising incidence of cardiovascular disease in India: Assessing its economic impact. J Preventive Cardiology 4(4): 735–740.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR et al. 2016. 2016 Esc/Eas guidelines for the management of dyslipidemias. The task force for the management of dyslipidemia of the European society of cardiology (Esc) and European atherosclerosis society (Eas) Eur Heart J 37(39):2999–3058. doi:10.1093/eurheartj/ehw272.
Ghobadi S, Hassanzadeh-Roastami Z, Mohammadian F, Zare M, Faghih S. 2019. Effects of canola oil consumption on lipid profile: A systematic review and meta-analysis of randomized controlled clinical trials. J Am Coll Nutr 38(2):185–196. https://doi.org/10.1080/07315724.2018.1475270.
Gupta R, Misra A, Vikram NK, Kondal D, Gupta SS, Agrawal A, Pandey RM. 2009. Younger age of escalation of cardiovascular risk factors in Asian Indian subjects. BMC Cardiovasc Disord 9(28). doi: 10.1186/1471-2261-9-28.
Gupta R, Sharma M, Goyal NK, Bansal P, Lodha S, Sharma KK. 2016. Gender differences in 7 years trends in cholesterol lipoproteins and lipids in India: Insights from a hospital database. Indian J Endocrinol Metab 20(2):211–218. doi: 10.4103/2230-8210.176362.
Guptha S, Gupta R, Deedwania P, Bhansali A, Maheshwari A, Gupta A, Gupta B, Saboo B, Singh J, Achari V et al. 2014. Cholesterol lipoprotein and prevalence of dyslipidemias among urban Asian Indian subjects: A cross sectional study. Indian Heart J 66(3):280–288. doi: 10.1016/j.ihj.2014.03.005.
Hernáez A, Castañer O, Elosua R, Pintó X, Estruch R, Salsa-Salvadó J, Corella D, Arós F, Serra-Majem Lluis, Fiol M et al. 2017. Mediterranean diet improves high-density lipoprotein function in high cardiovascular -risk individuals. Circulation 135(7):633–643. doi: 10.1161/CIRCULATIONAHA.116.023712.
[ICMR] Indian Council of Medical Research. 2010. Nutrient requirement and recommended dietary allowance for Indians. A report of the expert group of the Indian Council of Medical Research 2009. Jamai-Osmania (IN): ICMR.
Iggmann D, Gutaffson IB, Berglund L, Vessby B, Marckmann P, Risérus U. 2011. Replacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: A randomized control study. J Intern Med 270(4): 356–364. https://doi.org/10.1111/j.1365-2796.2011.02383.x.
Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, Pandey MR, Haque S, Mendis S, Rangarajan S et al. 2007. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 297:286–294. doi: 10.1001/jama.297.3.286.
Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandani VK, Joshi PP, Unnikrishnan R, Nirmal E, Subashini R et al. 2014. Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study. Plos One 9(5):e96808. https://doi.org/10.1371/journal.pone.0096808.
Kruse M, von Loeffelholz C, Hoffmann D, Pohlmann A, Seltmann AC, Osterhoff M, Hornemann S, Pivovarova O, Rohn S, Jahreis G et al. 2015. Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men. Mol Nutr Food Res 59(3):507–519. https://doi.org/10.1002/mnfr.201400446.
Kuriyan R, Gopinath N, Vaz M, Kurpad AV. 2005. Use of rice bran oil in patients with hyperlipidemia. Natl Med J India 18(6): 292–296.
McGowan MW, Artiss JD, Strandbergh DR, Zak B. 1983. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29(3):538–542. https://doi.org/10.1093/clinchem/29.3.538.
Mozaffarian D, Clarke R. 2009. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 63(2):S22–S33. https://doi.org/10.1038/sj.ejcn.1602976.
Nagao M, Nakajima H, Toh R, Hirata KI, Ishida T. 2018. Cardioprotective effects of high-density lipoprotein beyond its anti-atherogenic action. J Atheroscler Thromb 25(10):985–993. doi:10.5551/jat.RV17025.
NCEP-ATP III. 2002. Third report of national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 106(25):3143–3421.
[NHLBI] National Heart, Lung, and Blood Institute. 2005. Your Guide to Lowering Cholesterol with TLC. Maryland (USA): NHLBI.
Oliveras-López MJ, Molina JJ, Mir MV, Rey EF, Martin F, de la Serrana HLG. 2013. Extra virgin olive oil (evoo) consumption and antioxidant status in healthy institutionalized elderly humans. Arch Gerontol Geriatr 57(2):234–242. https://doi.org/10.1016/j.archger.2013.04.002.
Prabhakaran D, Jeemon P, Sharma M, Roth GA, Johnson C, Harikrishnan S, Gupta R, Pandian JD, Naik N, Roy A et al. 2018 The changing patterns of cardiovascular diseases and their risk factors in the states of India: The global burden of disease study 1990–2016. The Lancet Global Health 6(12):e1339–e1351. https://doi.org/10.1016/S2214-109X(18)30407-8.
Rifai N, Warnick GR. 1994. Ed. Laboratory measurement of lipids. Lipoproteins and apolipoproteins. Washington DC (USA): AACC Press.
Roeschlau P, Bernt E, Gruber W. 1974. Enzymatic determination of total cholesterol in serum. Z Klin Chem Klin Biochem 12(5):226.
Rosner B. 1995. Fundamentals of Biostatistics. 4th edition. Belmont (USA): Wadsworth Publishing Co Inc.
Saedi S, Noroozi M, Khosrotabar N, Mazandarani S, Ghadrdoost B. 2017. How canola and sunflower oils affect lipid profile and anthropometric parameters of participants with dyslipidemia. Med J Islam Repub Iran 31:5. doi:10.18869/mjiri.31.5.
Sai RA, Dhamodaran V, Thiagarajan P. 2012. Role of genetic variants in development of cardiovascular diseases. Int J Pharm Sci Health Care 1(2):45–53.
Seth V, Singh K. 2005. Diet Planning Through the Lifecycle Part I: Normal Nutrition, 4th edition. Elite Publishing House Pvt Ltd.
Tholstrup T, Hjerpsted J, Raff M. 2011. Palm olein increases plasma cholesterol moderately compared with olive oil in healthy individuals. Am J Clin Nutr 94(6):1426–1432. https://doi.org/10.3945/ajcn.111.018846.
Tietz NW, Burtis CA, Ashwood ER, Bruns DE. 2006. Tietz Textbook of Clinical Biochemistry and Molecular Diagnostics. 4th Ed. St. Louis (USA): Elsevier Saunders.
[WHO] World Health Organization. 2008. Global health observatory data repository. https://apps.who.int/gho/data/node.main.A884?lang=en [Accessed 21st June 2020].
[WHO] World Health Organization. 2011. Waist circumference and waist hip ratio. Report of a WHO expert consultation, Geneva, 8–11 December 2008. https://apps.who.int/iris/bitstream/handle/10665/44583/9789241501491_eng.pdf;jsessionid=30D03EDF96D8E4D2EDA61EE0A94BBC04?sequence=1. [Accessed 28th June 2019].
[WHO] World Health Organization. 2018. Global health estimates summary tables. Projection of deaths by cause, age and sex, by World Bank income group. http://www.who.int/healthinfo/global_burden_disease/en/. [Accessed 14th June 2019].
[WHO] World Health Organization. 2019. Obesity. https://www.who.int/topics/obesity/en/. [Accessed 28th June 2019].
Report of the Joint WHO/FAO expert consultation. 2003. Diet, nutrition and the prevention of chronic diseases. https://www.who.int/dietphysicalactivity/publications/trs916/en/. [Accessed 9th February 2020].
Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, Gupta R, Joshi P, Kerkar P, Thanikachalam S et al. 2008. Treatment and outcomes of acute coronary syndromes in India (Create): A prospective analysis of registry data. The Lancet 371(9622):1435–1442. doi: 10.1016/S0140-6736(08)60623-6.